BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 29, 2013
 |  BC Week In Review  |  Company News  |  Deals

AD Biotech, Quest Pharma deal

The companies formed a JV to develop immunotherapies for cancer. The companies will work together to co-develop products that combine their technologies. Quest PharmaTech said the deal gives it access to AD Biotech's antibody, protein transduction domain and manufacturing technologies. Quest PharmaTech...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >